Cytokinetics, Inc. (CYTK)
78.06
-0.71
(-0.90%)
USD |
NASDAQ |
May 21, 16:00
78.03
-0.03
(-0.04%)
After-Hours: 19:59
Cytokinetics Research and Development Expense (TTM) : 400.51M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.494B |
| Regeneron Pharmaceuticals, Inc. | 5.526B |
| Sarepta Therapeutics, Inc. | 896.74M |
| Moderna, Inc. | 2.69B |
| Revolution Medicines, Inc. | 1.117B |